India

Daily New Cases in India falls below 2 Lakh mark after 40 Days

In encouraging signs to India’s fight against COVID-19 pandemic, the Daily New Cases have fallen below 2 Lakh to a level seen 40 days before (Daily new cases were 1,84,372 on 14th April 2021). 1,96,427 Daily New Cases were registered in the last 24 hours.

https://static.pib.gov.in/WriteReadData/userfiles/image/image0013Q26.png

Cumulatively, the Active Caseload has also now reduced to 25,86,782. Active Cases have decreased since its last peak on 10th May 2021. A net decline of 1,33,934 is witnessed in the last 24 hours. It now comprises 9.60% of the country’s total Positive Cases.

https://static.pib.gov.in/WriteReadData/userfiles/image/image0029U5A.png

India’s Daily Recoveries continue to outnumber the Daily New Cases for the 12th consecutive day. 3,26,850 recoveries were registered in the last 24 hours.

India’s cumulative recoveries have reached 2,40,54,861 today. The National Recovery Rate has grown further to touch 89.26%.

https://static.pib.gov.in/WriteReadData/userfiles/image/image003ARO9.png

https://static.pib.gov.in/WriteReadData/userfiles/image/image004FHRR.png

A total of 20,58,112 tests were conducted in the last 24 hours in the country and cumulatively 33,25,94,176 tests have been done so far. The Daily Positivity rate has reduced and now stands at 9.54% today.

https://static.pib.gov.in/WriteReadData/userfiles/image/image005FWKM.png

A total of 19,85,38,999 vaccine doses have been administered through 28,41,151 sessions, as per the provisional report till 7 am today. These include 97,79,304 HCWs who have taken the 1st dose and 67,18,723HCWs who have taken the 2nddose, 1,50,79,964 FLWs (1stdose), 83,55,982 FLWs (2nddose), 1,19,11,759 beneficiaries under 18-44 age group (1stdose), 6,15,48,484 (1stdose) and 99,15,278 (2nd dose) beneficiaries aged 45 to 60 years. 5,69,15,863 1stdose beneficiaries and 1,83,13,642 2nd dose beneficiaries of more than 60 years old.

Show More

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button